Renal Insufficiency Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
The demand for renal disease treatment products and therapies has been incrementing steadily in the past few years, owing to the prevalence of poor kidney functions among a vast population base across the world, especially in the Asia Pacific region, and increased government support. However, the participants of the global renal insufficiency market must take a note of weak competition among the marketed products for the treatment of chronic kidney diseases (CKD). Currently, there are more than a dozen products marketed in the field, such as Erythropoietin (EPO), Angiotensin Converting Enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARB), phosphate binders, and iron replacement products. While most of these products are approved by regulatory bodies including FDA, their lack of effectiveness in order to control the escalation of chronic kidney diseases is discouraging the targeted patients to continue. Consequently, the global market for renal insufficiency desperately needs a first-in-class product, and research and development of the vendors will determine the leader among them in the near future.
The global renal insufficiency market is also gaining traction from poor safety profiles of the existing therapies. As there is an ample amount of unmet need and hence the market is ripe for the introduction of a therapy that meets the expectations. The severity of phosphate binders events associated with sevelamer hydrochloride, sevelamer carbonate, and lanthanum carbonate have given rise to a requirement of products with enhanced safety profiles and improved efficacy. This is another factors that augur well for the future of the market for renal insufficiency.
Renal insufficiency also referred to as kidney or renal failure is an ailment characterized by poor kidney function. In the last few years, the incidence of this condition has increased at such a pace that the demand for effective treatment for renal insufficiency is at all-time high. With governments around the world have increased their healthcare spending to battle the spread of chronic ailments, the investment in research and development of novel therapeutics for renal insufficiency is expected to show considerable increase.
The report studies the prevalent dynamics in the global renal insufficiency market and its potential growth opportunities in detail. It presents insights into the growth drivers and key restraints to help the stakeholders get a better perspective of the global renal insufficiency market.
The global renal insufficiency market is exhibiting impressive growth under the influence of drivers such as the increasing number of people with renal insufficiency, rising incidence of diabetes and blood pressure, and the rising number of dialysis centers worldwide. Of these, diabetes and blood pressure are regarded as the two main causes of renal insufficiency such as end stage renal diseases. In addition, the market is also witnessing increasing demand for home based dialysis as it helps in significantly reducing the cost incurred on treatment. Hence the rising demand for home based dialysis is also expected to have a positive impact on the overall market.
Regionally, Asia Pacific, North America, Europe, and Rest of the World constitute the key market segments. Among these, North America represented the leading regional market in 2013, trailed by Europe and Asia Pacific. The rising demand witnessed in the U.S. and Canada is the chief driver of the renal insufficiency market in North America. As per findings of the Center for Disease Control and Prevention, over 113,136 patients received treatment for end stage renal disease (ESRD) in 2011 in the U.S. alone. Over the course of the forecast period, the number if projected to increase further, which subsequently will create high demand for effective treatment and diagnosis solutions.
Between 2017 and 2025, the renal insufficiency market is expected to report impressive growth in Asia Pacific under the influence of persistent economic growth across emerging nations. Besides this, the market is also expected to gain from the increasing pool of patients suffering from renal diseases and the growing awareness about the availability of advanced treatment options.
To study the prevailing competition, the report includes profiles of companies such as Baxter Healthcare, DaVita Healthcare Partners Inc., Fresenius Medical Care AG, Nikkiso, Gambro AB, Fuso Pharmaceutical Industries Ltd., B. Braun Melsungen AG, Nipro Corporation, Terumo Corporation, Kawasumi Laboratories, Inc., and Asahi Kasei Medical Co. Ltd. Since these players actively participate in the market, their operations have a significant influence on the overall business dynamics.
To gauge the contribution of these companies towards the market’s growth, the report conducts SWOT analysis on them. It thus studies in detail the strengths and weaknesses of the companies profiled and also identifies the opportunities and threats that these companies are poised to witness over the course of the forecast period.
The reports at TMR Research provide qualitative solutions that break the barriers of doubt or uncertainties when the stakeholders plan to expand their growth reach. The researchers compile the necessary information that enlightens the CXOs about the current growth opportunities in a specific market and enables them to make the most of the opportunities.
TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others. TMR Research reports help the stakeholders and CXOs make impactful decisions through a unique blend of innovation and analytical thinking. The use of innovation and analytical thinking while structuring a report assures complete and ideal information of the current status of the market to the stakeholders.
TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors. The brilliance of the experts at TMR Research and their alacrity to conduct thorough research and create phenomenal reports makes TMR Research better than others.
5-Point Growth Formula
The 5-point growth formula developed by TMR Research provides an insight to the stakeholders and CXOs about the current situation in the market. The growth formula makes the report a perfect companion for the stakeholders and CXOs.
The 5-point growth formula includes the following points:
Current and Future Threats
Along with studying the opportunities necessary for growth, threats are also an important aspect to look upon for the companies and stakeholders in a specific sector. TMR Research studies every negative aspect that will hinder the growth of a specific area of business and includes it in the report. The stakeholders and CXOs will have the benefit of assessing the threat and take the necessary steps to prevent the hindrance caused due to the threats.
Accurate Trend Analysis
Keeping up with the latest trends is crucial in any business or sector. While stakeholders are aware of the trends that are on the surface, TMR Researchers find trends that are deeply entrenched in the particular market or sector. The reports are constantly updated with the latest trends so that the stakeholders and CXOs can derive benefits from the trends and generate good revenues.
Demography forms an important part of the growth pattern of all the markets. Diving deep into the demographics enables maximum output from specific areas. The TMR Research team assesses every region and picks out the vital points that have a large impact on the growth of a market.
The analysts at TMR Research conduct an all-round analysis on the competitive landscape of the market. The observations recorded by the analysts are added to the reports so that every stakeholder gets a glimpse of the competitive scenario and frame their business plans according to the situation.
The COVID-19 outbreak has changed the growth projections of numerous sectors and businesses. The analysts at TMR Research have conducted a conscientious survey on the markets after the pandemic struck. The analysts have put forth their brilliant and well-researched opinions in the report. The opinions will help the stakeholders to plan their strategy accordingly.
The reports offer answers to the top 7 questions that revolve around the growth of the market
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report